Gene-environment interaction and its impact on coronary heart disease risk

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 2, 2007, Pages 148-152

  Talmud, Philippa J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Coronary heart disease; Gene environment interaction; Risk

Indexed keywords

ALCOHOL DEHYDROGENASE; APOLIPOPROTEIN E;

ADULT; AGE DISTRIBUTION; AGED; COMORBIDITY; CORONARY ARTERY DISEASE; DRINKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; FEMALE; GENETICS; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SMOKING;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; APOLIPOPROTEINS E; COMORBIDITY; CORONARY DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SMOKING;

EID: 33846921101     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.01.008     Document Type: Review

References (24)

1. Austin M.A., Hutter C.M., Zimmern R.L., and Humphries S.E. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 160 (2004) 421-429
2. Ginsberg H.N., Kris-Etherton P., Dennis B., Elmer P.J., Ershow A., Lefevre M., et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 18 (1998) 441-449
3. Doll R, Hill AB. Mortality of British doctors in relation to smoking; observation on coronary thrombosis. In: Haenzel W, editor. Epidemiological approaches to the study of cancer and other chronic diseases. National Cancer Institute Monograph no.19, US Department of Health, Education and Welfare, Bethesda MD 1966:205-68.
4. Savolainen M.J., and Kesaniemi Y.A. Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol 6 (1995) 243-250
5. Haskell W.L. The influence of exercise training on plasma lipids and lipoproteins in health and disease. Acta Med Scand Suppl 711 (1986) 25-37
6. Shields P.G. Epidemiology of tobacco carcinogenesis. Curr Oncol Rep 2 (2000) 257-262
7. Wallace A.J., Mann J.I., Sutherland W.H., Williams S., Chisholm A., Skeaff C.M., et al. Variants in the cholesterol ester transfer protein and lipoprotein lipase genes are predictors of plasma cholesterol response to dietary change. Atherosclerosis 152 (2000) 327-336
8. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
9. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342 (1993) 697-699
10. Wilson P.W., Schaefer E.J., Larson M.G., and Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 16 (1996) 1250-1255
11. Humphries S.E., Talmud P.J., Hawe E., Bolla M., Day I.N., and Miller G.J. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 358 (2001) 115-119
12. Lahoz C., Schaefer E.J., Cupples L.A., Wilson P.W., Levy D., Osgood D., et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154 (2001) 529-537
13. Talmud P.J., Stephens J.W., Hawe E., Demissie S., Cupples L.A., Hurel S.J., et al. The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 69 (2005) 613-622
14. Marmot M.G., Smith G.D., Stansfeld S., Patel C., North F., Head J., et al. Health inequalities among British civil servants: the Whitehall II Study. Lancet 337 (1991) 1387-1393
15. Talmud P.J., Lewis S.J., Hawe E., Martin S., Acharya J., Marmot M.G., et al. No APOE 4 effect on CHD risk in a cohort with low smoking prevalence: the Whitehall II Study. Ann Hum Genet 177 (2003) 105-112
16. Slooter A.J., Bots M.L., Havekes L.M., del Sol A.I., Cruts M., Grobbee D.E., et al. Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam Study. Stroke 32 (2001) 1947-1952
17. Djousse L., Myers R.H., Province M.A., Hunt S.C., Eckfeldt J.H., Evans G., et al. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke (2002) 1357-1361
18. Karvonen J., Kauma H., Kervinen K., Ukkola O., Rantala M., Paivansalo M., et al. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J Hypertens 20 (2002) 2371-2378
19. Smith J.D., Miyata M., Poulin S.E., Neveux L.M., and Craig W.Y. The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent. Int J Clin Lab Res 28 (1998) 116-121
20. Jolivalt C., Leininger-Muller B., Bertrand P., Herber R., Christen Y., and Siest G. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic Biol Med 28 (2000) 129-140
21. Doll R., Peto R., Hall E., Wheatley K., and Gray R. Alcohol and coronary heart disease reduction among British doctors: confounding or causality?. Eur Heart J 18 (1997) 23-25
22. Bosron W.F., Lumeng L., and Li T.K. Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Mol Aspects Med 10 (1988) 147-158
23. Hines L.M., Stampfer M.J., Ma J., Gaziano J.M., Ridker P.M., Hankinson S.E., et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 344 (2001) 549-555
24. Younis J., Cooper J.A., Miller G.J., Humphries S.E., and Talmud P.J. Genetic variation in alcohol dehydrogenase 1C and the beneficial effect of alcohol intake on coronary heart disease risk in the Second Northwick Park Heart Study. Atherosclerosis 180 (2005) 225-232